UnknownNot applicableNCT04353050
Atypical MOLes and Melanoma Early Detection Study (MoleMed)
Studying Familial atypical multiple mole melanoma syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Russian Academy of Medical Sciences
- Principal Investigator
- Igor V Samoylenko, MD, PhDN.N. Blokhin Russian Cancer Research Center of Russian MoH
- Intervention
- Non-invasive adhesive system (patch)(procedure)
- Enrollment
- 350 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2020 – 2023
Study locations (2)
- N.N. Blokhin Russian Cancer Research Center, Moscow, Moscow, Russia
- Privolzhsky Research Medical University of the Ministry of Health of the Russian Federation, Nizhny Novgorod, Russia
Collaborators
Blokhin's Russian Cancer Research Center
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04353050 on ClinicalTrials.govOther trials for Familial atypical multiple mole melanoma syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT06599619Effects of Anti-PD1 Adjuvant Checkpoint Blockade Immunotherapy on Atypical/Dysplastic NeviJohn Kirkwood
- RECRUITINGNCT04095195Registry of Subjects at Risk of Pancreatic CancerAssociazione Italiana per lo Studio del Pancreas
- RECRUITINGNCT05446155BioMEL- Diagnostic and Prognostic Factors in Melanoma.Region Skane
- RECRUITINGNCT00040352Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of MelanomaNational Cancer Institute (NCI)
See all trials for Familial atypical multiple mole melanoma syndrome →